Illinois Supreme Court Tightens Standing for No-Injury Consumer Claims — The Consumer Finance Podcast
Work This Way: A Labor & Employment Law Podcast | Service Animals, the ADA, and Workplace Rights
Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare
From Diligence to Post-Closing: What’s Shifting in 2026 Health Care Transactions
Private Equity Investment in Health Care
Healthcare Trend Report: A Review of the Pharmacy and Drug Supply Chain Sectors
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — Payments Pros – The Payments Law Podcast
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — The Consumer Finance Podcast
AGG Talks: Government Insight for Life Sciences Leaders | Patient Assistance Programs and the False Claims Act: Enforcement Trends and Compliance Risks for Life Sciences Companies
Health-e Law Episode 19: From AI to OBBBA: Healthcare Law Insights from the 2025 WHLC Leadership Summit with Amy Dilcher and Chi Huynh, WHLC Co-Chairs
Video Overview: Healthcare Trend Report - A Review of the Pharmacy and Drug Supply Chain Sectors
Concierge Practices: Understanding the Model and Its Unique Challenges
Beyond the Bylaws: The Medical Staff Show - How to Build Compliant and Effective Peer Review Processes into Your Bylaws, Part 2
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 264: 2026 Healthcare Industry Trends & Challenges with Lauren DeMoss and Matthew Roberts
Investors Prepare to Navigate FDA Crosswinds Ahead of the J.P. Morgan Healthcare Conference
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 263: Building NC's Innovation Ecosystem with Andrea Conner of First Flight Venture Center
Hospice Insights Podcast - Hospital to Hospice: Managing Referrals and Relationships
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 262: Breaking the “Undruggable” Barrier with Marcel Frenkel of Ten63 Therapeutics
12 Days of Regulatory Insights: Day 7 – Tobacco and Nicotine Regulatory Roundup — Regulatory Oversight Podcast
Navigating FDA's 2025 AI Guidance: Risk-Based Framework, Public Comments, and Generative Models - The Good Bot Podcast
Virginia and Illinois have become the third and fourth states to enact laws requiring manufacturers of baby food to test products for heavy metals (lead, cadmium, arsenic, and mercury) and make the results publicly available....more
Key Takeaways: In a rare unfavorable advisory opinion, OIG concluded that certain sign-on bonuses for home care workers are a risk under the federal Anti-Kickback Statute, despite historical reliance on the Employment...more
Key Takeaways - The Declaration. Secretary Kennedy’s declaration concludes that pediatric gender-affirming care does not constitute a “safe and effective treatment” and that practitioners who furnish such services fall...more
Introduction and Summary - HHS issued a final rule modernizing 42 CFR Part 2 to implement the CARES Act and more closely align with HIPAA's Privacy, Breach Notification, and Enforcement frameworks. The rule permits a single,...more
Key Takeaways - Court approves landmark settlement expanding access to proton beam radiation therapy (PBRT). Final approval of an $8.75 million ERISA class action settlement requires UnitedHealthcare to revise its PBRT...more
The convergence of artificial intelligence (AI) and life sciences is no longer a distant promise. Companies operating in the sector are actively embracing the technology and are already achieving measurable results. In the...more
With the learnings of this report in mind, five priorities emerge for companies aiming to translate their AI ambitions into concrete, lasting advantage...more
1: AI is integral to business strategy - Three-quarters of life sciences companies say that AI is either crucial or very important to their business strategy. Within that, 68 percent of medical device companies and 56...more
Embracing AI is a strategic imperative for companies across the life sciences value chain, with the technology now a prerequisite for innovation, efficiency and future-readiness. The overwhelming consensus from our survey...more
AI is reshaping the life sciences industry in ways that are no longer hypothetical. The question is no longer whether to adopt AI, but how, and where, it can drive the most value. Adoption, however, is advancing at different...more
According to the Department of Justice’s (DOJ) January 16, 2026 press release, the DOJ reported a record $6.8 billion in settlements and judgments under the False Claims Act (FCA) for the fiscal year ending September 30,...more
2026 is shaping up to be a pivotal year for health care reimbursement. From major CMS payment rules to evolving disclosure requirements, AI scrutiny, and mounting pressure on providers across the care continuum, the 2026...more
Across the life sciences sector, funding is being tied more closely to operational goals. Risk and legal teams are setting boundaries around data use, model oversight and accountability, while finance teams are unlocking...more
According to the U.S. Bureau of Labor Statistics, unintentional drug overdoses led to 525 occupational deaths in 2022. In New York, opioid overdose deaths have increased more than 360 percent—from 1,074 deaths in 2010 to...more
New Jersey Gov. Murphy signed into law A3451/S2950 to greatly expand employer coverage and employee eligibility under the New Jersey Family Leave Act (NJFLA) on Jan. 18, 2026, as one of his last acts before leaving office....more
On January 5, 2026, the U.S. Department of Labor’s Wage and Hour Division (DOL) issued Opinion Letter FMLA2026-2, confirming that eligible employees may use Family Medical Leave Act (FMLA) leave for time spent traveling to...more
With life sciences organizations moving from experimentation to implementation, AI is becoming a core enabler of innovation across the value chain. The technology is now supporting real-time decisions, and the scope of...more
The U.S. Department of Justice (“DOJ”) has released its annual statistics on enforcement under the federal False Claims Act (“FCA”), reporting more than $6.8 billion in settlements and judgments for fiscal year (“FY”) 2025,...more
PepsiCo’s acquisition of the prebiotic soda line Poppi and Hershey’s acquisition of healthy snack maker LesserEvil reflect an ever-growing theme in the food and beverage space: premiumization....more
Earlier this week, we released a +Insight called “Healthcare in 2026: A preview” that lays out major legislative and regulatory healthcare actions that we expect to see in 2026....more
On January 6, 2026, the US Food and Drug Administration (FDA) issued two revised guidance documents relating to general wellness products (General Wellness Guidance) and clinical decision support software (CDS Software...more
After years of delays, the Centers for Medicare & Medicaid Services (CMS) is preparing to update the Clinical Laboratory Fee Schedule’s (CLFS) reimbursement rates for clinical diagnostic laboratory tests (CDLTs) that aren’t...more
On January 6, 2026, the US Food and Drug Administration (FDA) revised its final guidance on Clinical Decision Support Software (2026 CDS Software Guidance)....more
At the end of 2024, we predicted that the healthcare mergers and acquisitions (M&A) market would pick up steam in 2025, given the combination of decreasing interest rates, a potential shift in the regulatory landscape with...more
A federal judge has paused the merger of the only two companies developing a heart device made for high-risk patients suffering from aortic regurgitation, a potentially dangerous condition that occurs when the heart’s aortic...more
